] , “Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion (SCORE2) Report 18”, JAMA Ophthalmol, vol. 140, no. 5, pp. 458-464, 2022.
, “Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods.”, Subst Abus, vol. 43, no. 1, pp. 917-924, 2022.
, “Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.”, J Clin Oncol, p. JCO2102440, 2022.
, “Cumulative Lactation and Clinical Metabolic Outcomes at Mid-Life among Women with a History of Gestational Diabetes.”, Nutrients, vol. 14, no. 3, 2022.
, “Development of a Generic Physiologically-Based Pharmacokinetic Model for Lactation and Prediction of Maternal and Infant Exposure to Ondansetron via Breast Milk.”, Clin Pharmacol Ther, 2022.
, “Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum.”, J Infect Dis, 2022.
, “EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil.”, Trials, vol. 23, no. 1, p. 185, 2022.
, “First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E.”, Antimicrob Agents Chemother, vol. 66, no. 4, p. e0173221, 2022.
, “Frontloading in the Real-world Leveraging Smartphone Technology to Examine Rate of Alcohol Consumption Effects on Subjective Responses in Heavy Drinkers”, in 45th Annual Speaker & Poster Abstracts of the Research Society on Alcoholism, Orlando, Florida, 2022.
, “Frontloading In The Real-World: Leveraging Smartphone Technology To Examine Rate Of Alcohol Consumption Effects On Subjective Responses In Heavy Drinkers”, in 45th Annual Speaker & Poster Abstracts of the Research Society on Alcoholism, Orlando, Florida, 2022.
, “HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial.”, Addiction, 2022.
, “Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD.”, Bone Marrow Transplant, vol. 57, no. 2, pp. 302-303, 2022.
, “MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.”, Vaccine, vol. 40, no. 10, pp. 1472-1482, 2022.
, “Maternal body composition and gestational weight gain in relation to asthma control during pregnancy.”, PLoS One, vol. 17, no. 4, p. e0267122, 2022.
, “Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion”, Am J Ophthalmol, vol. 240, pp. 330-341, 2022.
, “A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial.”, Transplant Cell Ther, 2022.
, “The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study.”, Addiction, 2022.
, “Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy.”, Matern Child Health J, 2022.
, “A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.”, Vaccine, vol. 40, no. 9, pp. 1271-1281, 2022.
, “A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects.”, Clin Transl Sci, vol. 15, no. 7, pp. 1592-1598, 2022.
, “Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation.”, J Natl Med Assoc, 2022.
, “Qualitative results from NIDA grant”, Maternal Child Health, 2022.
, “Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.”, J Clin Oncol, vol. 40, no. 4, pp. 356-368, 2022.
, “Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.”, Lancet Infect Dis, vol. 22, no. 8, pp. 1210-1220, 2022.
, “Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial.”, JAMA Pediatr, vol. 176, no. 3, pp. 253-261, 2022.